<?xml version="1.0" encoding="UTF-8"?>
<ref id="B73-vaccines-08-00531">
 <label>73.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wo≈∫niakowski</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Mazur-Panasiuk</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Walczak</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Juszkiewicz</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Frant</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Niemczuk</surname>
    <given-names>K.</given-names>
   </name>
  </person-group>
  <article-title>Attempts at the development of a recombinant African swine fever virus strain with abrogated EP402R, 9GL, and A238L gene structure using the CRISPR/Cas9 system</article-title>
  <source>J. Vet. Res.</source>
  <year>2020</year>
  <volume>64</volume>
  <fpage>197</fpage>
  <lpage>205</lpage>
  <pub-id pub-id-type="doi">10.2478/jvetres-2020-0039</pub-id>
  <pub-id pub-id-type="pmid">32587905</pub-id>
 </element-citation>
</ref>
